learning from experience
On World Cancer Day 2025, the GLIOMATCH project participated in the EU project showcase hosted by HaDEA, highlighting the role of EU-funded research in advancing cancer care. We have seized this opportunity to map the EU Cancer Mission project landscape.
On the 10th anniversary of the International Day of Women and Girls in Science, GLIOMATCH celebrates the women driving our research and our commitment to gender balance in science and leadership.
On World Cancer Day 2025, the GLIOMATCH project participated in the EU project showcase hosted by HaDEA, highlighting the role of EU-funded research in advancing cancer care. We have seized this opportunity to map the EU Cancer Mission project landscape.
The GLIOMATCH project has received ethical approval from the UZ/KU Leuven Ethics Committee to conduct retrospective clinical trials for adult and paediatric glioma patients. This follows earlier approvals for other project partners, setting data collection to begin in 2025,.
Spatial proteomics, a technique which maps protein distributions within tissues with high resolution, is central to the GLIOMATCH project.
GLIOMATCH was featured at the European Cancer Summit 2024, held on 20–21 November in Brussels and online. We’re proud to support Europe’s fight against cancer.
GLIOMATCH project coordinator, Prof Frederik de Smet, held a lecture about how immunotherapy can be harnessed for brain cancer research.
Glioblastoma Awareness Day (GBM Day) on 17 July 2024 aimed to raise awareness and support for those affected by glioblastoma, an aggressive brain tumour. GLIOMATCH’s month-long campaign is summarised in this article, highlighting the critical need for further research.
The GLIOMATCH project kick-off meeting took place from 25-27 March 2024 and was hosted by KU Leuven, the project coordinator, at the Faculty Club in Leuven, Belgium. This marks the first in-person gathering of the project’s 14 partner institutions.
According to the World Health Organisation, cancer ranks as the world’s second-leading cause of death. Brain tumours have particularly high mortality rates. The GLIOMATCH project is set to rewrite this narrative.
